: Differentiation of mESCs into ureteric bud progenitor cells. (A) Brightfield images of mESCs in monolayer (2D) cultures during differentiation into UB progenitor cells. Consecutive days are shown. Scale bars, 200 µm. (B) RT-PCR displays mESC differentiation into epiblasts but not to extraembryonic endoderm at day 2, primitive streak but no ectoderm at day 4 and intermediate mesoderm but no ectoderm). β-actin was used as a housekeeping gene, E16.5 kidney, E11.5 UB and mESC were used as a control. Cell-specific markers: Afp, extraembryonic endoderm; Pax6, ectoderm; coexpression of Pax6 and Sox1, ectoderm. (C) RT-PCR at day 9 of differentiation showing the expression of markers of UB progenitors while ectodermal marker Pax6 was not detected; E11.5 UB was used as positive control. (D) qPCR graphs show lack of nephron specific marker expression in day 9 differentiated cells.
structures when treated with 10 µM DAPT from day 3 to 11. Notch inhibition suppressed the proximal tubule (LTL+, green) formation, but the UB (Ecad+, yellow) and glomerular (Synpo+, red) structures developed normally. n = 5; Scale bars, 20 μm. (B) Representative immunohistochemistry images of renal structures treated with gentamicin (5 mg/ml) from day 9 to 11 (48 hours) or cisplatin (5, 20, 50 μM) from day 10 to 11 (24 hours). Apoptotic cells were detected by cleaved caspase 3 antibody-staining (Casp3). n = 6; Scale bars, 20 μm. (C) Quantification of number of apoptotic proximal tubular cells in kidney organoids treated with gentamicin (G) (5 mg/ml) and cisplatin (C) (5, 20, 50 μM) at indicated doses. Data are expressed as mean ± s.e.m. (n=5); ** -p<0.01; *** -p<0.001. S1: Primers (5'-3') used in the study.
Gene name
Forward primer sequence Reverse primer sequence 
